The firms will use nFerence's Agentic AI platform to analyze real-world treatment patterns in 700 patients' charts and inform personalized care.

We recently published a list of 20 Mid-Cap Stocks Insiders Were Buying in Q1 2025. In this article, we are going to take a ...

L'Oreal's eye cream is formulated with super hydrating flavonoids that are known to possess both antioxidant and ...

The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease (PD) and anti-tau therapies, which are ...

US firms have been on top of the lateral hiring market and performed strongly in Managing IP's Americas Awards and the IP ...

Lori Vallow Daybell, known for her doomsday religious beliefs, faces trial in Arizona for conspiring to murder her husband ...

Pfizer and Flagship Pioneering have entered into an agreement aimed at discovering potential selective inhibitors for ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

Current healthcare reforms have increased the demand for public health educators, health promotion specialists, and allied health professionals. The University of Houston’s Bachelor of Science Health ...

Pfizer (PFE) and Pioneering Medicines, Flagship Pioneering’s in-house drug discovery and development unit, announced an agreement to discover ...